Feighery C, McDonald G S, Greally J F, Weir D G
Clin Exp Immunol. 1981 Jul;45(1):143-51.
In this study 45 patients with a variety of liver diseases did not demonstrate T lymphocyte sensitivity to liver-specific protein (LSP) as assessed by lymphocyte transformation whereas LSP-immunized rabbits developed both cellular and humoral immunity to this antigen. Although these LSP-immunized rabbits demonstrated portal tract inflammation with some hepatocyte necrosis, rabbits immunized with antigens known to contaminate LSP developed similar lesions. These findings contrast with those of other investigators who have reported immune responsiveness to LSP in liver patients and chronic active hepatitis in LSP-immunized rabbits. In determining the significance of these studies it must be emphasized that all preparations of LSP contain an heterogeneous group of antigens and that the specific sensitizing antigen has yet to be identified.
在本研究中,45例患有各种肝脏疾病的患者,经淋巴细胞转化评估,未表现出T淋巴细胞对肝特异性蛋白(LSP)的敏感性,而用LSP免疫的兔对该抗原产生了细胞免疫和体液免疫。尽管这些用LSP免疫的兔表现出门道炎症并伴有一些肝细胞坏死,但用已知污染LSP的抗原免疫的兔也出现了类似病变。这些发现与其他研究者的结果形成对比,其他研究者报告了肝病患者对LSP有免疫反应,以及用LSP免疫的兔出现慢性活动性肝炎。在确定这些研究的意义时,必须强调的是,所有LSP制剂都包含一组异质性抗原,并且尚未鉴定出特异性致敏抗原。